Cascade Biochem Ltd., a wholly owned subsidiary of Johnson Matthey plc, is a leader in the development, manufacture and supply of PROSTAGLANDINS and related products for pharmaceutical applications. The company also produces LEUKOTRIENES for clinical research and a number of other products relating to POLYUNSATURATED FATTY ACID METABOLISM.
The company has R&D laboratories (shown left) in Reading UK operating under ISO9002 certified management systems and a new purpose built cGMP compliant product development and manufacturing facility in Cork, Ireland (shown below). The Cork facility was approved by the US FDA in May 2001 for the production of non-sterile APIs produced by chemical synthesis. The inspection was based on Misoprostol. The facilities were certified ICH Q7A GMP compliant by the Irish Medicines Board in July 2003.